Onkos Surgical gets FDA De Novo approval of antibacterial orthopedic implants
Onkos Surgical earned the FDA's De Novo approval for its antibacterial-coated orthopedic implants, the medtech company said April 8.
Stay updated with breaking news from Steven Gitelis. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Onkos Surgical earned the FDA's De Novo approval for its antibacterial-coated orthopedic implants, the medtech company said April 8.
Onkos Surgical this week announced it received FDA de novo approval for its antibacterial coated orthopedic implants.
/PRNewswire/ -- Burn Surgeon Dr. Todd Huzar was recognized by AlloSource®, one of the largest allograft providers in the U.S., with its sixth annual Dr. Steven...
/PRNewswire/ -- Onkos Surgical, a leading innovator of solutions for musculoskeletal oncology and complex orthopaedic procedures, presented its plans for...
/PRNewswire/ -- AlloSource®, one of the largest allograft providers in the U.S., creating innovative cellular and tissue products to help surgeons heal their...